Estrogen Receptor Positive Breast Cancer Treatment Market Gets Push from Government Aid
The global estrogen receptor positive (ER+) breast cancer treatment market was valued at USD 19.8 billion in 2023 and is projected to reach USD 33.7 billion by 2030, expanding at a CAGR of 7.89% from 2024 to 2030. This growth is propelled by advancements in drug development, increased awareness and screening, rising incidence rates of breast cancer, and strategic industry...
0 Comments 0 Shares 5 Views 0 Reviews